Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 43.32
+1.62 (3.88%)
Nov 10, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 37.12 billion as of November 9, 2026. It is the 3,692nd most valuable company in the world and the 189th biggest in Hong Kong. Its market cap has increased by 231.95% in one year.
Market Cap
37.12B
Enterprise Value
36.92B
Revenue
2.15B
Global Rank
Country Rank
#189 Hong Kong
PE Ratio
43.83
ChartMarket Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 37.12B, an increase of 259.93%. That is a compound annual growth rate of 35.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 37.12B | 57.40% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akeso | 83.48B |
| Genscript Biotech | 71.43B |
| RemeGen | 54.24B |
| 3SBio | 37.78B |
| Shanghai Junshi Biosciences | 31.92B |
| Shanghai Henlius Biotech | 27.14B |
| InnoCare Pharma | 25.79B |
| Zai Lab | 25.64B |